Stay updated on Epacadostat and Pembrolizumab in Advanced Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Epacadostat and Pembrolizumab in Advanced Pancreatic Cancer Clinical Trial page.

Latest updates to the Epacadostat and Pembrolizumab in Advanced Pancreatic Cancer Clinical Trial page
- Check2 days agoChange DetectedRevision: v3.3.3 is now displayed; HHS Vulnerability Disclosure and Revision: v3.3.2 have been removed.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRevision history updated to add v3.3.2 and remove v3.3.1. These are administrative metadata changes that do not modify study content.SummaryDifference0.1%

- Check31 days agoChange DetectedAdded Revision: v3.3.1; Deleted Revision: v3.2.0.SummaryDifference0.1%

- Check38 days agoChange DetectedThe notice about a lapse in government funding has been removed from the Study Details page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check53 days agoChange DetectedThe page now shows the study Withdrawn with sponsor support ended. This indicates the trial is no longer active and enrollment is unlikely to proceed.SummaryDifference0.4%

- Check81 days agoChange DetectedKey updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.SummaryDifference3%

Stay in the know with updates to Epacadostat and Pembrolizumab in Advanced Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Epacadostat and Pembrolizumab in Advanced Pancreatic Cancer Clinical Trial page.